HYPOTHESIS TESTING:

100 participants are randomly selected to receive the new COVID-19 J&J vaccine. Roughly 3% of other COVID-19 vaccines experience a blood clot on patients. Among the 100 participants of the J&J vaccine, 10 experience blood clots. The J&J company wants you to show a hypothesis test at the 1% level to find out if their J&J vaccine has the SAME blood clot rate as the other COVID-19 vaccines OR A HIGHER blood clot rate.

note: please show a hypothesis test indicating the null & alternative hypothesis as well as the test statistic and p-value.